This award will allow us to continue and intensify our CRISPR-based studies to identify novel drug targets to overcome cancer drug resistance.
https://www.cancerfonden.se/forskning/for-forskare/samtliga-anslagsbeslut
The Wermeling lab at the Karolinska Institutet
– Research related to Autoimmunity, Cancer immunotherapy, and CRISPR/Cas9
This award will allow us to continue and intensify our CRISPR-based studies to identify novel drug targets to overcome cancer drug resistance.
https://www.cancerfonden.se/forskning/for-forskare/samtliga-anslagsbeslut
Many congratulations!